Ibritumomab Intravenous and Opium Deodorized
Determining the interaction of Ibritumomab Intravenous and Opium Deodorized and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: opium
Brand name: Opium Deodorized, Paregoric
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Opium preparation
- Ibritumomab Intravenous-Opium Tincture
- Ibritumomab Intravenous-Oprelvekin
- Ibritumomab Intravenous-Oprelvekin Subcutaneous
- Ibritumomab Intravenous-Opsumit
- Ibritumomab Intravenous-Opti-Clear
- Opium Deodorized-Ibritumomab Tiuxetan
- Opium Deodorized-Ibrutinib
- Opium Deodorized-Ibrutinib Capsules
- Opium Deodorized-Ibrutinib Tablets
- Opium Deodorized-Ibu
- Opium Deodorized-IBU Tablets